Ali Divan

Ali Divan, Ph.D., is an accomplished biotechnology professional and founder of Trulitica, established in July 2023. Currently serving as a Council Member at Medical Excellence Capital, LLC since August 2023, Ali Divan specializes in cell and gene therapies, proteins/peptides, small molecules, and antibodies, focusing on areas such as immunology and oncology. Prior to these roles, Ali Divan held various positions in research and development, including Staff Scientist at Proteintech Genomics and Spatial Genomics, and Senior Scientist for Technology Transfer at Truvian. A background in operational management and quality control was gained at BioLegend, alongside a postdoctoral fellowship at the University of North Dakota. Ali Divan earned a Ph.D. in Medical Sciences from Texas A&M Health Science Center and a BS in Biochemistry from California State University, Chico.